Volume 18, Number 2—February 2012
Research
Pathogenesis of Avian Bornavirus in Experimentally Infected Cockatiels
Table 2
Bird | Died, dpi | Euthanized, dpi | Antibody titer† | Dilatation of proventriculus‡ | Antigen detection§ |
Infectious virus¶ | |
---|---|---|---|---|---|---|---|
p14 | p24 | ||||||
ic1 | 10,240 | 2 | + | + | + | ||
ic2 | – | 206 | 5,120 | 3 | + | + | + |
ic3 | – | 60 | 20,480 | 1 | + | + | + |
ic4 | – | 115 | 20,480 | 0 | + | + | + |
ic5 | – | 115 | 20,480 | 0 | + | + | + |
ic6 | – | 230 | 5,120 | 0 | + | + | + |
ic7 | 66 | – | 1,0240 | 0 | + | + | + |
ic8 | – | 230 | 1,0240 | 0 | + | + | + |
ic9 | – | 115 | 5,120 | 0 | + | + | + |
iv1 | – | 230 | 10,240 | 2 | + | + | + |
iv2 | – | 229 | 5,120 | 2 | + | + | + |
iv3 | 120 | – | 10,240 | 2 | + | − | + |
iv4 | – | 116 | 5,120 | 1 | + | + | + |
iv5 | – | 116 | 20,480 | 0 | + | + | + |
iv6 | – | 229 | 10,240 | 0 | + | + | + |
iv7 | – | 229 | 10,240 | 0 | + | + | + |
iv8 | – | 116 | 5,120 | 0 | + | + | + |
iv9 | – | 229 | 20,480 | 0 | + | + | + |
se1 | – | 229 | <10 | 0 | − | − | − |
*Proventricular dilatation disease was confirmed in all birds by histopathologic confirmation of lymphoplasmacytic infiltrates of/near ganglia in the central nervous system and/or upper gastrointestinal tract. ABV, avian bornavirus; dpi, days postinoculation; ic, intracerebrally inoculated; +, positive; −, negative; iv, intravenously inoculated; se, sentinel.
†Antibodies against avian bornavirus detected by use of indirect immunofluorescence assay; titers <10.0 are considered negative.
‡0, no dilatation; 1, mild dilatation; 2, moderate dilatation; 3, severe dilatation.
§Detection of the X-protein (p14) and the phosphoprotein (p24) of Borna disease virus by immunohistochemical testing.
¶Re-isolation of infectious ABV in quail cell line CEC-32.
Page created: January 17, 2012
Page updated: January 17, 2012
Page reviewed: January 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.